LONG-TERM SAFETY AND EFFICACY OF CANAKINUMAB VS TRIAMCINOLONE ACETONIDE IN PATIENTS WITH FREQUENT ACUTE GOUTY ARTHRITIS ATTACKS WHO ARE CONTRAINDICATED, INTOLERANT OR UNRESPONSIVE TO NSAIDS AND/OR COLCHICINE

被引：1
|
作者：
Alten, R.
Schlesinger, N. [1 ]
So, A. [2 ]
Schumacher, H. R. [3 ,4 ]
Bloch, M. T. [5 ]
Machein, U. [6 ]
Richard, D. [6 ]
Lheritier, K. [6 ]
Bardin, T. [7 ]
机构：
[1] Rutgers RWJMS, New Brunswick, NJ USA
[2] CHU Vaudois, Serv Rhumatol, Lausanne, Switzerland
[3] Univ Penn, Philadelphia, PA 19104 USA
[4] VA Med Ctr, Philadelphia, PA USA
[5] Holdsworth House Med Practice, Sydney, NSW, Australia
[6] Novartis Pharma AG, Basel, Switzerland
[7] Hop Lariboisiere, F-75475 Paris, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.1807
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0537
引用
收藏
页码：785 / 785
页数：1
相关论文
共 41 条
  • [1] Long-Term Efficacy and Safety of Canakinumab Versus Triamcinolone Acetonide in Acute Gouty Arthritis Patients.
    Brown, J. P.
    So, A.
    Dikranian, A.
    Alten, R.
    Bardin, T.
    Schumacher, H. R.
    Gimona, A.
    Krammer, G.
    Karpov, A.
    Schlesinger, N.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S396 - S396
  • [2] EFFECT OF CANAKINUMAB VS TRIAMCINOLONE ACETONIDE FOR TREATMENT OF GOUTY ARTHRITIS IN PATIENTS WHO ARE UNABLE TO USE NSAIDS AND COLCHICINE OR WITH SEVERE GOUTY ARTHRITIS
    Schlesinger, N.
    Alten, R.
    Bardin, T.
    Bloch, M.
    Shpilsky, A.
    Krammer, G.
    Kiechle, T.
    So, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 439 - 439
  • [3] CANAKINUMAB (ACZ885) VS TRIAMCINOLONE ACETONIDE FOR TREATMENT OF ACUTE FLARES AND PREVENTION OF RECURRENT FLARES IN GOUTY ARTHRITIS PATIENTS REFRACTORY TO OR CONTRAINDICATED TO NSAIDS AND/OR COLCHICINE
    So, Alexander
    Meulemeester, Marc D.
    Bodalia, Bhavesh
    Shamim, Talha
    Pikhlak, Andrey
    Yucel, A. Eftal
    Arulmani, Udayasankar
    Richard, Dominik
    Murphy, Valda
    Sallstig, Peter
    Schlesinger, Naomi
    RHEUMATOLOGY, 2010, 49 : I60 - I61
  • [4] Efficacy and Safety Of Canakinumab Pre-Filled Syringe Versus Triamcinolone Acetonide In Acute Gouty Arthritis Patients
    Sunkureddi, Prashanth
    Toth, Edith
    Brown, Jacques P.
    Moericke, Ruediger
    Nebesky, Jan Michael
    Krammer, Gerhard
    Tao, Aiyang
    John, Markus
    Kivitz, Alan
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S498 - S498
  • [5] Canakinumab in Frequently Flaring Gouty Arthritis Patients, Contraindicated, Intolerant or Unresponsive to non-Steriodal Anti-Inflammatory drugs and/or Colchicine: Safety and Efficacy Results from Long Term Follow-up.
    Schlesinger, Naomi
    Alten, Rieke
    Bardin, Thomas
    Schumacher, H. Ralph, Jr.
    Bloch, Mark
    Lheritier, Karine
    Richard, Dominik
    Stancati, Andrea
    So, Alexander
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S66 - S67
  • [6] Long-Term Safety of Canakinumab in Patients with Gouty Arthritis.
    So, Alexander
    Alten, Reike
    Schumacher, H. Ralph
    Bloch, Mark
    Bardin, Thomas
    John, Markus R.
    Krammer, Gerhard
    Nebesky, Jan Michael
    Tao, Aiyang
    Schlesinger, Naomi
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S63 - S63
  • [7] SAFETY AND EFFICACY OF CANAKINUMAB IN FREQUENTLY FLARING GOUTY ARTHRITIS PATIENTS WHO ARE CONTRAINDICATED, INTOLERANT OR UNRESPONSIVE TO NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND/OR COLCHICINE: RESULTS FROM 3 YEARS FOLLOW-UP
    Alten, R.
    Bardin, T.
    Bloch, M.
    Lheritier, K.
    Machein, U.
    Junge, G.
    So, A.
    Schlesinger, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 544 - 544
  • [8] A 3-Year Follow-up Study of Canakinumab in Frequently Flaring Gouty Arthritis Patients, Contraindicated, Intolerant, or Unresponsive to Nonsteroidal Anti-Inflammatory Drugs and/or Colchicine
    Schlesinger, Naomi
    Bardin, Thomas
    Bloch, Mark
    Lheritier, Karine
    Machein, Uwe
    Junge, Guido
    So, Alexander
    Alten, Rieke
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [9] Efficacy and Safety of Canakinumab Vs Triamcinolone Acetonide in Patients with Gouty Arthritis Unable to Use Nonsteroidal Anti-Inflammatory Drugs and Colchicine, and On Stable Urate Lowering Therapy (ULT) or Unable to Use ULT
    Bardin, T.
    So, A.
    Alten, R.
    Bloch, M.
    John, M. R.
    Krammer, G.
    Nebesky, J. M.
    Tao, A.
    Schlesinger, N.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S811 - S812
  • [10] Efficacy of canakinumab (ACZ885) compared to triamcinolone acetonide for treatment of acute flares and prevention of recurrent flares in gouty arthritis patients
    So, A.
    De Meulemeester, M.
    Pikhlak, A.
    Yucel, A. E.
    Arulmani, U.
    Richard, D.
    Murphy, V.
    Sallstig, P.
    Schlesinger, N.
    SWISS MEDICAL WEEKLY, 2010, 140 : 8S - 8S
12345